AstraZeneca Forxiga gets Chinese nod to treat CKD with and without type 2 diabetes Ruchika Sharma6 Sept 2022 11:15 AM ISTForxiga (dapagliflozin) is a first-in-class, oral, once-daily SGLT2 inhibitor.
AstraZeneca gets USFDA nod for Imfinzi plus chemotherapy to treat advanced biliary tract cancer Ruchika Sharma5 Sept 2022 1:30 PM ISTBiliary tract cancer is a group of rare and aggressive cancers that occur in the bile ducts and gallbladder.
AstraZeneca Tagrisso gets Japanese okay for early-stage EGFR-mutated lung cancer Ruchika Sharma30 Aug 2022 9:45 AM ISTNew Delhi: AstraZeneca's Tagrisso (osimertinib) has been approved in Japan for the adjuvant treatment of patients with epidermal growth factor...
Siam Bioscience reports record profit after COVID vaccine deal with AstraZeneca Ruchika Sharma29 Aug 2022 10:45 AM ISTBangkok: Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began...
AstraZeneca gets Japenese nod for Ultomiris to treat generalised myasthenia gravis Ruchika Sharma29 Aug 2022 9:30 AM ISTgMG is a rare, debilitating, chronic, autoimmune neuromuscular disease that leads to a loss of muscle function and severe weakness.
AstraZeneca may not stay in vaccine business in long run: CEO Ruchika Sharma24 Aug 2022 2:57 PM ISTAstraZeneca is also looking for bolt-on acquisitions, including small and mid-sized companies specialising in oncology and cardiovascular treatments,...
AstraZeneca India breast cancer drug lynparza gets DCGI okay Isra Zaman22 Aug 2022 5:15 PM ISTAstraZeneca India, a science-led biopharmaceutical company, has announced that it has received a Drugs Controller General of India (DCGI) approval to...
DCGI nod to AstraZeneca India breast cancer drug Lynparza Ruchika Sharma20 Aug 2022 11:49 AM ISTEarly breast cancer is defined as the cancer confined to the breast with or without regional lymph node involvement and the absence of distant...
AstraZeneca, Alveofit collaborate to boost lung diseases treatment in India Ruchika Sharma17 Aug 2022 10:00 AM ISTAs a part of this partnership with Alveofit, AstraZeneca will provide Alveofit IoT enabled handheld spirometers to the clinics and last mile...
AstraZeneca concludes acquisition of TeneoTwo Ruchika Sharma15 Aug 2022 11:00 AM ISTAstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m.
AstraZeneca, Daiichi Sankyo get USFDA accelerated nod for Enhertu for HER2 Mutant Non-small Cell Lung Cancer Ruchika Sharma14 Aug 2022 3:30 PM ISTEnhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi...
AstraZeneca new tablet formulation of Calquence gets USFDA okay Ruchika Sharma8 Aug 2022 12:30 PM IST"The tablet can be taken with gastric acid-reducing agents, including proton pump inhibitors (PPIs), antacids and H2-receptor antagonists (H2RAs),"...
